IDBR
Infectious Disease Board Review

Stopping PJP prophylaxis in HIV - Trip Gulick, MD/ Michael Saag, MD


Listen Later

A 44-year-old man was diagnosed with Pneumocystis pneumonia as his AIDS-defining illness and begun on antiretroviral therapy with 2 nucleosides and an integrase inhibitor during his hospitalization. He stabilizes and follows up for repeated outpatient visits with an HIV RNA consistently <20 copies/ml and a CD4 cell count of 44 that increased to 163 (at 3 months), 232 (at 6 months), 242 (at 9 months), and was repeated at 243 (at 12 months).


His current medications are: tenofovir alafenamide/emtricitabine, dolutegravir, trimethoprim-sulfa double strength daily, and azithromycin 1200 mg once weekly. He says he’s tired of taking pills and would like to stop some of them.


What do you recommend?

A. Stop tenofovir alafenamide/emtricitabine

B. Stop trimethoprim-sulfa

C. Stop azithromycin

D. Stop trimethoprim-sulfa and azithromycin

E. Continue the current regimen


⁠www.idbrcourse.org/⁠  © 2024 IDBR LLC | All Rights Reserved

...more
View all episodesView all episodes
Download on the App Store

IDBR
Infectious Disease Board ReviewBy John Bennett, MD / Henry Masur, MD

  • 5
  • 5
  • 5
  • 5
  • 5

5

2 ratings